eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



insulin glulisine
Apidra Pharmaceutical company:
Sanofi-Aventis
www.sanofi-aventis.us

NEW INDICATION & DOSAGE
To control hyperglycemia in adults with diabetes under medical supervision in a clinical setting using I.V. administration--
Adults: Dosage should be individualized with close monitoring of blood glucose and potassium levels to maintain good glycemic control and minimize adverse effects.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins